156 related articles for article (PubMed ID: 21204698)
1. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
Radvansky J; Ficek A; Kadasi L
Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
[TBL] [Abstract][Full Text] [Related]
2. Upgrading molecular diagnostics of myotonic dystrophies: multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs.
Radvansky J; Ficek A; Kadasi L
Mol Cell Probes; 2011 Aug; 25(4):182-5. PubMed ID: 21550396
[TBL] [Abstract][Full Text] [Related]
3. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
Radvanszky J; Surovy M; Polak E; Kadasi L
Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
[TBL] [Abstract][Full Text] [Related]
4. Validation of sensitivity and specificity of tetraplet-primed PCR (TP-PCR) in the molecular diagnosis of myotonic dystrophy type 2 (DM2).
Catalli C; Morgante A; Iraci R; Rinaldi F; Botta A; Novelli G
J Mol Diagn; 2010 Sep; 12(5):601-6. PubMed ID: 20616365
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
[TBL] [Abstract][Full Text] [Related]
6. Premutation allele pool in myotonic dystrophy type 2.
Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
[TBL] [Abstract][Full Text] [Related]
7. Optimization PCR for Detection CTG/CCTG-Repeat Expansions in the Diagnosis of Myotonic Dystrophies.
Meng YX; Shen HR; Zhao Z; Bing Q; Li N; Hu J
Ann Clin Lab Sci; 2015; 45(5):502-7. PubMed ID: 26586700
[TBL] [Abstract][Full Text] [Related]
8. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
9. Effect of unexpected sequence interruptions to conventional PCR and repeat primed PCR in myotonic dystrophy type 1 testing.
Radvansky J; Ficek A; Minarik G; Palffy R; Kadasi L
Diagn Mol Pathol; 2011 Mar; 20(1):48-51. PubMed ID: 21326039
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
12. Distribution and Structure of DM2 Repeat Tract Alleles in the German Population.
Mahyera AS; Schneider T; Halliger-Keller B; Schrooten K; Hörner EM; Rost S; Kress W
Front Neurol; 2018; 9():463. PubMed ID: 29973908
[TBL] [Abstract][Full Text] [Related]
13. Molecular Diagnosis of Myotonic Dystrophy.
Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
[TBL] [Abstract][Full Text] [Related]
14. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
16. Triplet-primed PCR is more sensitive than southern blotting-long PCR for the diagnosis of myotonic dystrophy type1.
Addis M; Serrenti M; Meloni C; Cau M; Melis MA
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1428-31. PubMed ID: 23030650
[TBL] [Abstract][Full Text] [Related]
17. Modification of the triplet repeat primed polymerase chain reaction method for detection of the CTG repeat expansion in myotonic dystrophy type 1: application in preimplantation genetic diagnosis.
Kakourou G; Dhanjal S; Mamas T; Serhal P; Delhanty JD; SenGupta SB
Fertil Steril; 2010 Oct; 94(5):1674-9. PubMed ID: 20171614
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a relatively high proportion of DM2 mutations in a large group of Polish patients.
Sulek A; Lusakowska A; Krysa W; Rajkiewicz M; Kaminska A; Nojszewska M; Kostera-Pruszczyk A; Zdzienicka E; Kubalska J; Rakowicz M; Szirkowiec W; Kwiecinski H; Zaremba J
Neurol Neurochir Pol; 2018; 52(6):736-742. PubMed ID: 29588063
[TBL] [Abstract][Full Text] [Related]
19. Analysis of repetitive regions in myotonic dystrophy type 1 and 2.
Carson NL
Curr Protoc Hum Genet; 2009 Apr; Chapter 9():Unit 9.6. PubMed ID: 19360700
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]